In PCa, increased expression of hypoxia-induced proteins correlates with treatment failure, independent of tumor stage, Gleason score, and prostate-specific antigen (PSA) levels (Deep and Panigrahi, 2015). The gene discussed is PROS1; the disease is posterior cortical atrophy.